Back
37
Day Range
$54.42
$55.34
52-Week Range
$50.76
$73.18
Volume
1,827,988
50D / 200D Avg
$58.63
/
$56.59
Prev Close
$54.13
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (626 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | 30.2 | 0.4 |
| P/B | 1.7 | 2.9 |
| ROE % | 5.9 | 3.8 |
| Net Margin % | 10.8 | 3.9 |
| Rev Growth 5Y % | 14.9 | 10.0 |
| D/E | 0.1 | 0.2 |
Key Takeaways
Revenue grew 14.93% annually over 5 years — strong growth
Earnings declined -18.26% over the past year
Debt/Equity of 0.11 — conservative balance sheet
Generating 724.96M in free cash flow
P/E of 30.20 — premium valuation
Cash machine — converts 207.78% of earnings into free cash flow
Growth
Revenue Growth (5Y)
14.93%
Revenue (1Y)12.87%
Earnings (1Y)-18.26%
FCF Growth (3Y)240.39%
Quality
Return on Equity
5.94%
ROIC5.95%
Net Margin10.83%
Op. Margin16.56%
Safety
Debt / Equity
0.11
Current Ratio5.21
Interest Coverage48.95
Valuation
P/E Ratio
30.20
P/B Ratio1.73
EV/EBITDA18.49
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 12.87% | Revenue Growth (3Y) | 15.39% |
| Earnings Growth (1Y) | -18.26% | Earnings Growth (3Y) | 44.26% |
| Revenue Growth (5Y) | 14.93% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 3.22B | Net Income (TTM) | 348.90M |
| ROE | 5.94% | ROA | 4.59% |
| Gross Margin | 77.13% | Operating Margin | 16.56% |
| Net Margin | 10.83% | Free Cash Flow (TTM) | 724.96M |
| ROIC | 5.95% | FCF Growth (3Y) | 240.39% |
| Safety | |||
| Debt / Equity | 0.11 | Current Ratio | 5.21 |
| Interest Coverage | 48.95 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | 30.20 | P/B Ratio | 1.73 |
| P/S Ratio | 3.27 | PEG Ratio | -1.71 |
| EV/EBITDA | 18.49 | Dividend Yield | 0.00% |
| Market Cap | 10.54B | Enterprise Value | 9.87B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 3.22B | 2.85B | 2.42B | 2.10B | 1.85B |
| Net Income | 348.90M | 426.86M | 167.65M | 141.56M | -64.08M |
| EPS (Diluted) | 1.80 | 2.21 | 0.88 | 0.75 | -0.35 |
| Gross Profit | 2.48B | 2.27B | 1.89B | 1.59B | 1.38B |
| Operating Income | 533.48M | 484.21M | 185.77M | 160.97M | -82.34M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 7.59B | 6.99B | 6.84B | 6.38B | 6.00B |
| Total Liabilities | 1.51B | 1.33B | 1.89B | 1.77B | 1.74B |
| Shareholders' Equity | 6.09B | 5.66B | 4.95B | 4.60B | 4.27B |
| Total Debt | 642.87M | 649.47M | 1.10B | 1.09B | 1.09B |
| Cash & Equivalents | 1.31B | 942.84M | 755.13M | 724.53M | 587.28M |
| Current Assets | 3.95B | 3.23B | 2.96B | 2.75B | 2.27B |
| Current Liabilities | 759.03M | 606.99M | 1.18B | 588.88M | 546.50M |
Strategy Scores
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
Custom
Cash Flow Compounder
#687 of 1024
Recent Activity
Entered
Cash Flow Compounder
Mar 24, 2026